These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2373198)

  • 1. Retention of topical liposomal formulations on the cornea.
    McCalden TA; Levy M
    Experientia; 1990 Jul; 46(7):713-5. PubMed ID: 2373198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.
    Law SL; Huang KJ; Chiang CH
    J Control Release; 2000 Jan; 63(1-2):135-40. PubMed ID: 10640587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes in topical drug delivery.
    Schaeffer HE; Krohn DL
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):220-7. PubMed ID: 7056633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
    Abdul Nasir NA; Agarwal P; Agarwal R; Iezhitsa I; Alyautdin R; Nukolova NN; Chekhonin VP; Mohd Ismail N
    Drug Deliv; 2016 Oct; 23(8):2765-2771. PubMed ID: 26289215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precorneal factors influencing the ocular distribution of topically applied liposomal inulin.
    Lee VH; Takemoto KA; Iimoto DS
    Curr Eye Res; 1984 Apr; 3(4):585-91. PubMed ID: 6713957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impregnation of collagen corneal shields with liposomes: uptake and release of hydrophilic and lipophilic marker substances.
    Grammer JB; Kortüm FA; Wolburg H; Lüdtke R; Schmidt KH; Thiel HJ; Pleyer U
    Curr Eye Res; 1996 Aug; 15(8):815-23. PubMed ID: 8921224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo.
    Zhang HH; Luo QH; Yang ZJ; Pan WS; Nie SF
    Drug Deliv; 2011; 18(7):502-10. PubMed ID: 21790329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of corneal penetration of 125I-labelled idoxuridine liposome.
    Dharma SK; Fishman PH; Peyman GA
    Acta Ophthalmol (Copenh); 1986 Jun; 64(3):298-301. PubMed ID: 3751519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
    Sun KX; Wang AP; Huang LJ; Liang RC; Liu K
    Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.
    Hathout RM; Mansour S; Mortada ND; Guinedi AS
    AAPS PharmSciTech; 2007 Jan; 8(1):1. PubMed ID: 17408209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film.
    Vicario-de-la-Torre M; Benítez-del-Castillo JM; Vico E; Guzmán M; de-Las-Heras B; Herrero-Vanrell R; Molina-Martínez IT
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7839-47. PubMed ID: 25377221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
    J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
    Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
    Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms.
    Bochot A; Mashhour B; Puisieux F; Couvreur P; Fattal E
    J Drug Target; 1998; 6(4):309-13. PubMed ID: 9894698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of nanoliposomes containing cyclosporine a after ocular administration.
    Mosallaei N; Banaee T; Farzadnia M; Abedini E; Ashraf H; Malaekeh-Nikouei B
    Curr Eye Res; 2012 Jun; 37(6):453-6. PubMed ID: 22577761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting liposomal corneal anesthetics.
    Zhan C; Santamaria CM; Wang W; McAlvin JB; Kohane DS
    Biomaterials; 2018 Oct; 181():372-377. PubMed ID: 30099260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in the rabbit.
    Fitzgerald P; Hadgraft J; Wilson CG
    J Pharm Pharmacol; 1987 Jun; 39(6):487-90. PubMed ID: 2886611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.
    Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y
    Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular drug targeting by liposomes and their corneal interactions.
    Velpandian T; Gupta SK; Gupta YK; Biswas NR; Agarwal HC
    J Microencapsul; 1999; 16(2):243-50. PubMed ID: 10080117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
    Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
    Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.